These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19633689)

  • 1. Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?
    Keung YK; Levitan D; Zamkoff K; Hurd D
    Bone Marrow Transplant; 2010 Feb; 45(2):407-8. PubMed ID: 19633689
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
    Hamadani M; Benson DM; Lin TS; Porcu P; Blum KA; Devine SM
    Eur J Haematol; 2008 Dec; 81(6):425-31. PubMed ID: 18774954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
    Krishnan A; Nademanee A; Fung H; Angelopoulou M; Molina A; Gaal K; Dagis A; Palmer J; Alvarnas J; Slovak M; Kogut N; Popplewell L; Rodriguez R; Schriber J; Wang S; Forman SJ
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):641-7. PubMed ID: 16737937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic transplantation in malignant lymphoma].
    Stötzer OJ; Schleuning M; Ledderose G; Hiddemann W; Kolb HJ
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1062-9. PubMed ID: 11602913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
    Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease.
    Seyfarth B; Josting A; Dreyling M; Schmitz N
    Br J Haematol; 2006 Apr; 133(1):3-18. PubMed ID: 16512824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical courses of Hodgkin's disease and other malignant lymphomas.
    Lee YT; Say C; Hori JM; Spratt JS
    Am J Roentgenol Radium Ther Nucl Med; 1973 Jan; 117(1):19-29. PubMed ID: 4568243
    [No Abstract]   [Full Text] [Related]  

  • 9. The curability of follicular lymphoma.
    Lunning M; Armitage JO
    Transfus Apher Sci; 2007 Aug; 37(1):31-5. PubMed ID: 17936072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem cell transplantation in lymphoma.
    Schmitz N; Buske C; Gisselbrecht C
    Semin Hematol; 2007 Oct; 44(4):234-45. PubMed ID: 17961722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
    Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R
    Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual sequence of lymphoid disorders: follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma.
    Niscola P; Palombi M; Fratoni S; Trawinska MM; Scaramucci L; Giovannini M; Perrotti A; De Fabritiis P
    Acta Oncol; 2009; 48(7):1073-4. PubMed ID: 19308758
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy-related myelodysplastic syndrome with inv(16)(p13q22) and I type CBFbeta/MYH11 after autologous transplantation: undetectable fusion transcript in pretransplant progenitor cells.
    Yamamoto K; Nishikawa S; Minagawa K; Yakushijin K; Okamura A; Matsui T
    Leuk Res; 2006 Mar; 30(3):354-61. PubMed ID: 16165210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Al-Mansour M; Connors JM; Gascoyne RD; Skinnider B; Savage KJ
    J Clin Oncol; 2010 Feb; 28(5):793-9. PubMed ID: 20048177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Sirvent A; Dhedin N; Michallet M; Mounier N; Faucher C; Yakoub-Agha I; Mohty M; Robin M; Tabrizi R; Clement L; Bilger K; Larosa F; Contentin N; Huyn A; François S; Bulabois CE; Ceballos P; Bourrhis JH; Buzyn A; Cornillon J; Guillerm G; de Revel T; Bay JO; Guilhot F; Milpied N
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):78-85. PubMed ID: 19744569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
    Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.
    Nyman H; Jantunen E; Juvonen E; Elonen E; Böhm J; Kosma VM; Enblad G; Karjalainen-Lindsberg ML; Leppä S
    Bone Marrow Transplant; 2008 Jul; 42(2):93-8. PubMed ID: 18391989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Lin TS; Copelan EA
    Curr Hematol Rep; 2003 Jul; 2(4):310-5. PubMed ID: 12901328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.